Skip to main content

Upcoming Webinar

Laptop computer.

Critical decisions in critical care: BLING III

Date: 23rd October 2025
Starts: 14:00 BST (13:00 UTC, 09:00 EDT)
Duration: 30 minutes

Join us for an expert-led webinar exploring how the landmark BLING III study is shaping antibiotic dosing strategies in the ICU. Discover what the latest evidence means for continuous versus intermittent β-lactam infusions in critically ill patients—and how to apply it effectively in your practice.Whether you're a pharmacist, intensivist, nurse or health professional inside or outside the ICU, this session will equip you with practical insights and tools to support evidence-based decision-making at the bedside.

Register

By the end of this webinar, you will be able to:

  • Understand the clinical implications of the BLING III study — including key outcomes and what they mean for ICU antibiotic administration strategies.
  • Recognise when and how to implement continuous β-lactam infusions in clinical practice, with practical tips on dosing, drug stability, and patient selection.
  • Navigate Critical Illness on MedicinesComplete to access evidence-based recommendations, expert commentary, and dosing guidance at the point of care.

Why this matters?

With increasing evidence supporting prolonged antibiotic infusions, and practical implementation guidance now available, this session will help you stay ahead of evolving standards in critical care antimicrobial therapy.

Hosted by:

Leo Chen
International Account Manager

Speakers:

Professor Cathy McKenzie
Consultant Pharmacist in Critical Care at University Hospital Southampton and is a visiting Research Fellow at University of Southampton, School of Medicines and a Visiting Senior Lecturer in Critical Care Pharmacy at Kings College London.

Register for this webinar now

Simply fill in the form below to access this webinar. All fields are required.

We collect and process data in accordance with our Privacy Policy.

Disclaimer

MedicinesComplete is aimed at health professionals and assumes a level of professional training to interpret the information on this site. Information on the selection and clinical use of medicines is designed for prescribers, pharmacists and other health professionals and is not suitable for patients or the general public. All information should be interpreted in light of professional knowledge and supplemented as necessary with specialist publications, and all users are responsible for ensuring appropriate use or reliance on such information. Although RPS make reasonable efforts to update the information on MedicinesComplete, RPS make no representations, warranties or guarantees, whether express or implied, that the content is accurate, complete, or up to date. So far as permitted by law, RPS will not accept liability for damages, in any form, arising from or in relation to MedicinesComplete, or for a temporary inability to access this site. For more information please see our Website Terms and Conditions. © The Royal Pharmaceutical Society, 2025. Copying of MedicinesComplete content without permission is not permitted.

Access the essential knowledge you need today

Medicines Complete.

Instant online access to our essential knowledge 24/7

Book a demo

Pharmaceutical Journal.

The Royal Pharmaceutical Society’s official journal

Subscribe

Pharmacy Knowledge.

Trusted knowledge and revision for tomorrow's pharmacists

ONtrack

Research Journals.

High impact research in pharmaceutical sciences

Read